What are the indications for liver transplantation in children with Wilson disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Indications for Liver Transplantation in Children with Wilson Disease

Liver transplantation is indicated for children with Wilson disease presenting with acute liver failure or decompensated chronic liver disease unresponsive to medical therapy, and should be considered urgently in these scenarios. 1, 2

Primary Indications

Acute Liver Failure (ALF)

  • Immediate transplant evaluation is mandatory for children presenting with Wilsonian acute liver failure 1, 2
  • This represents the most urgent indication, as pharmacological therapy is often insufficient to save life 3
  • Children with ALF have higher perioperative complexity but achieve excellent long-term survival (88.5% in recent series) 4
  • Decision-making tools include:
    • King's New Wilson Index (KNWI) - higher scores indicate greater urgency
    • PELD/MELD scores - typically elevated (average 27.8-35 in ALF cases) 4, 5
    • Presence of encephalopathy, ongoing hemolysis, and coagulopathy 4

Decompensated Chronic Liver Disease

Transplant evaluation should be initiated when children develop:

  • Poor weight gain and growth failure
  • Variceal hemorrhage
  • Intractable ascites
  • Recurrent cholangitis or spontaneous bacterial peritonitis
  • Advancing encephalopathy
  • Uncorrectable coagulopathy 1

Importantly, children with chronic advanced liver disease have superior outcomes compared to ALF presentations (90% vs 73% survival in some series), making timely referral before acute decompensation critical 2

Medical Treatment Failure

  • Children with chronic liver disease who fail to respond to chelating agents (penicillamine or trientine) should be referred for transplant evaluation 2, 6
  • All symptomatic patients should receive chelating agents as first-line therapy, but transplant should not be delayed if deterioration continues 2

Emerging Indication: Neurological Disease

  • A controversial but increasingly recognized indication is severe neurological manifestations with stable or compensated liver function 6, 7
  • Rationale: Early transplantation may prevent irreversible neurological deterioration by correcting the underlying copper metabolism defect 6
  • However, severe neurological deterioration can also occur post-transplant, making patient selection critical 2
  • Neurological improvement post-transplant is documented in most cases, with progressive score improvements over 6-30 months 6

Critical Timing Considerations

The key pitfall is delayed referral. Children should be referred for transplant evaluation before they develop:

  • Severe encephalopathy requiring mechanical ventilation (32% of ALF cases) 4
  • Need for continuous renal replacement therapy (46.5% of ALF cases) 4
  • Multi-organ failure

Early referral allows for:

  • Optimization of medical therapy while awaiting transplant
  • Living donor evaluation (which provides excellent outcomes and corrects the metabolic defect even when donors are obligate heterozygotes) 2, 4
  • Preoperative stabilization with therapeutic plasma exchange if needed 4

Contraindications to Consider

While the guidelines emphasize identifying contraindications during evaluation 1, absolute contraindications are rare in Wilson disease given the young age and absence of comorbidities typical in these patients. The transplant team should assess for active infection, severe cardiopulmonary disease, or other standard transplant contraindications.

Outcomes

  • Overall patient survival is excellent: 90-91% at 1 year and 86-89% at 5 years 8, 9
  • No disease recurrence occurs post-transplant, as the metabolic defect is corrected 5
  • Children transplanted for chronic liver disease have superior outcomes to those with ALF 9
  • Living donor liver transplantation is safe and effective, with 94.3% survival at median 26-month follow-up 4

Common Pitfalls

  • Waiting too long: Don't delay referral hoping for medical therapy response in deteriorating patients
  • Underestimating neurological indications: Consider transplant for severe neurological disease even with stable liver function 6
  • Inadequate preoperative assessment: ALF patients require intensive perioperative support including potential mechanical ventilation, CRRT, and therapeutic plasma exchange 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.